FDA-Approved solution to reliably and efficiently deliver actionable viral load insights to post-transplant patients and their care teams.
Cytomegalovirus (CMV) infection is a common complication that affects organ transplant patients. CMV, a member of the herpes virus family, establishes a lifelong latent infection that is generally asymptomatic. However, in immunocompromised patients, such as transplant recipients, reactivation of latent CMV is often life-threatening. Guidelines recommend regular monitoring of CMV viral load as an aid for diagnosis of CMV infections and monitoring response to treatment.
Monitor Viral Load
Assess viral response to treatment with
serial DNA measurements in patients receiving
Aid in the management of solid-organ transplant patients and hematopoietic stem cell transplant patients.